FDA.reportPublic FDA data

Myqorzo 10 MG Oral Tablet

RxCUI
2731480
RxNorm name
Myqorzo 10 MG Oral Tablet
Display name
Myqorzo 10 MG Oral Tablet
Full name
Myqorzo 10 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MYQORZOAFICAMTENCytokinetics Inc.fd778507-1274-4d1a-a659-5431d55c543a2025-12-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2731480

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
fd778507-1274-4d1a-a659-5431d55c543aMyqorzo 10 MG Oral Tablet [PSN] · aficamten 10 MG Oral Tablet [Myqorzo] [SBD] · Myqorzo 10 MG Oral Tablet [SY]32These highlights do not include all the information needed to use MYQORZO safely and effectively. See full prescribing information for MYQORZO. MYQORZO™ (aficamten) tablets, for oral use Initial U.S. Approval: 202520251216